Patent · US Active

Anti-PD-1/anti-VEGF natural antibody structure like heterodimeric form bispecific antibody and preparation thereof

US11827697B2 · kind B2 · utility

0Cited by
4References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 2, 2019
Grant dateNov 28, 2023
Priority date
Expiry dateMay 3, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An anti-PD-1/anti-VEGF natural antibody structure-like heterodimeric form bispecific antibody and preparation thereof. Provided are a highly stable, heterodimeric form anti-PD-1/anti-VEGF bispecific antibody having natural IgG characteristics and free of mismatched heavy and light chains and preparation method for the antibody. The bispecific antibody is capable of simultaneously binding with two target molecules and provides improved efficacy in treating a complicated disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.